Pharming (PHAR) Change in Working Capital (2019 - 2025)
Pharming (PHAR) posted Change in Working Capital of $14.1 million for Q4 2025, up 239.78% on a QoQ basis from -$10.1 million in Q4 2024, and up 239.78% year-over-year from $4.1 million in Q4 2024.
Pharming (PHAR) Change in Working Capital (2019 - 2025) Analysis & Trends
Pharming's Change in Working Capital history runs 7 years deep, the most recent figure standing at $14.1 million for Q4 2025.
- Quarterly Change in Working Capital rose 239.78% year-over-year to $14.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (up 473.6% YoY) and the FY2024 annual result came in at $10.1 million, down 40.62% from the prior year.
- Change in Working Capital was $14.1 million for Q4 2025 at Pharming, up from -$10.1 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $14.1 million in Q4 2025 and bottomed at -$10.1 million in Q4 2024.
- A 5-year average of $550745.4 and a median of -$518272.8 in 2021 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2021 — Change in Working Capital sank 64471.58% — and 2022, when it surged 5546.07%.
- Pharming's Change in Working Capital stood at -$1.1 million in 2021, then tumbled by 395.8% to -$5.4 million in 2022, then jumped by 80.11% to -$1.1 million in 2023, then slumped by 833.46% to -$10.1 million in 2024, then soared by 239.78% to $14.1 million in 2025.
- Business Quant data shows PHAR's Change in Working Capital at $14.1 million in Q4 2025, -$10.1 million in Q4 2024, and $7.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.08 Mn |
| Dec 31, 2025 | 14.08 Mn |
| Dec 31, 2024 | -10.07 Mn |
| Dec 31, 2024 | -10.07 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Dec 31, 2022 | -5.42 Mn |
| Dec 31, 2022 | -5.42 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Dec 31, 2021 | -1.09 Mn |
| Dec 31, 2021 | -1.09 Mn |
| Sep 30, 2021 | 42,454.34 |
| Sep 30, 2021 | 42,454.34 |